Cargando…

Mucoid Acinetobacter baumannii enhances anti-phagocytosis through reducing C3b deposition

BACKGROUND: Multidrug resistant (MDR) Acinetobacter baumannii causes serious infections in intensive care units and is hard to be eradicated by antibiotics. Many A. baumannii isolates are identified as the mucoid type recently, but the biological characteristics of mucoid A. baumannii and their inte...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Xiaoxia, Zhao, Qian, Wu, Yifan, Zhou, Hongwei, Ding, Shuangyang, Zhu, Kui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521736/
https://www.ncbi.nlm.nih.gov/pubmed/36186828
http://dx.doi.org/10.3389/fmed.2022.879361
_version_ 1784799906689449984
author Gong, Xiaoxia
Zhao, Qian
Wu, Yifan
Zhou, Hongwei
Ding, Shuangyang
Zhu, Kui
author_facet Gong, Xiaoxia
Zhao, Qian
Wu, Yifan
Zhou, Hongwei
Ding, Shuangyang
Zhu, Kui
author_sort Gong, Xiaoxia
collection PubMed
description BACKGROUND: Multidrug resistant (MDR) Acinetobacter baumannii causes serious infections in intensive care units and is hard to be eradicated by antibiotics. Many A. baumannii isolates are identified as the mucoid type recently, but the biological characteristics of mucoid A. baumannii and their interactions with host cells remains unclear. METHODS: The mucoid phenotype, antimicrobial susceptibility, biofilm-forming ability, acid resistance ability, peroxide tolerance, and in vivo toxicity of clinical ICUs derived A. baumannii isolates were first investigated. Secondly, the phagocytic resistance and invasive capacity of A. baumannii isolates to macrophages (MH-S, RAW264.7) and epithelial cells (A549) were analyzed. Furthermore, the abundance of C3b (complement factor C3 degradation product) deposition on the surface of A. baumannii was investigated. Last, the relationship between C3b deposition and the abundance of capsule in A. baumannii isolates were analyzed. RESULTS: These A. baumannii strains showed different mucoid phenotypes including hyper mucoid (HM), medium mucoid (MM), and low mucoid (LM). All tested strains were MDR with high tolerance to either acid or hydrogen peroxide exposure. Notably, these mucoid strains showed the increase of mortality in the Galleria mellonella infection models. Besides, the HM strain exhibited less biofilm abundance, higher molecular weight (MW) of capsule, and greater anti-phagocytic activity to macrophages than the LM strain. Together with the increased abundance of capsule, high expression of tuf gene (associated with the hydrolysis of C3b), the HM strain effectively inhibits C3b deposition on bacterial surface, resulting in the low-opsonization phenotype. CONCLUSION: Capsular characteristics facilitate the anti-phagocytic activity in hyper mucoid A. baumannii through the reduction of C3b deposition. Mucoid A. baumannii exhibits high phagocytosis resistance to both macrophages and epithelial cells.
format Online
Article
Text
id pubmed-9521736
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95217362022-09-30 Mucoid Acinetobacter baumannii enhances anti-phagocytosis through reducing C3b deposition Gong, Xiaoxia Zhao, Qian Wu, Yifan Zhou, Hongwei Ding, Shuangyang Zhu, Kui Front Med (Lausanne) Medicine BACKGROUND: Multidrug resistant (MDR) Acinetobacter baumannii causes serious infections in intensive care units and is hard to be eradicated by antibiotics. Many A. baumannii isolates are identified as the mucoid type recently, but the biological characteristics of mucoid A. baumannii and their interactions with host cells remains unclear. METHODS: The mucoid phenotype, antimicrobial susceptibility, biofilm-forming ability, acid resistance ability, peroxide tolerance, and in vivo toxicity of clinical ICUs derived A. baumannii isolates were first investigated. Secondly, the phagocytic resistance and invasive capacity of A. baumannii isolates to macrophages (MH-S, RAW264.7) and epithelial cells (A549) were analyzed. Furthermore, the abundance of C3b (complement factor C3 degradation product) deposition on the surface of A. baumannii was investigated. Last, the relationship between C3b deposition and the abundance of capsule in A. baumannii isolates were analyzed. RESULTS: These A. baumannii strains showed different mucoid phenotypes including hyper mucoid (HM), medium mucoid (MM), and low mucoid (LM). All tested strains were MDR with high tolerance to either acid or hydrogen peroxide exposure. Notably, these mucoid strains showed the increase of mortality in the Galleria mellonella infection models. Besides, the HM strain exhibited less biofilm abundance, higher molecular weight (MW) of capsule, and greater anti-phagocytic activity to macrophages than the LM strain. Together with the increased abundance of capsule, high expression of tuf gene (associated with the hydrolysis of C3b), the HM strain effectively inhibits C3b deposition on bacterial surface, resulting in the low-opsonization phenotype. CONCLUSION: Capsular characteristics facilitate the anti-phagocytic activity in hyper mucoid A. baumannii through the reduction of C3b deposition. Mucoid A. baumannii exhibits high phagocytosis resistance to both macrophages and epithelial cells. Frontiers Media S.A. 2022-09-15 /pmc/articles/PMC9521736/ /pubmed/36186828 http://dx.doi.org/10.3389/fmed.2022.879361 Text en Copyright © 2022 Gong, Zhao, Wu, Zhou, Ding and Zhu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Gong, Xiaoxia
Zhao, Qian
Wu, Yifan
Zhou, Hongwei
Ding, Shuangyang
Zhu, Kui
Mucoid Acinetobacter baumannii enhances anti-phagocytosis through reducing C3b deposition
title Mucoid Acinetobacter baumannii enhances anti-phagocytosis through reducing C3b deposition
title_full Mucoid Acinetobacter baumannii enhances anti-phagocytosis through reducing C3b deposition
title_fullStr Mucoid Acinetobacter baumannii enhances anti-phagocytosis through reducing C3b deposition
title_full_unstemmed Mucoid Acinetobacter baumannii enhances anti-phagocytosis through reducing C3b deposition
title_short Mucoid Acinetobacter baumannii enhances anti-phagocytosis through reducing C3b deposition
title_sort mucoid acinetobacter baumannii enhances anti-phagocytosis through reducing c3b deposition
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521736/
https://www.ncbi.nlm.nih.gov/pubmed/36186828
http://dx.doi.org/10.3389/fmed.2022.879361
work_keys_str_mv AT gongxiaoxia mucoidacinetobacterbaumanniienhancesantiphagocytosisthroughreducingc3bdeposition
AT zhaoqian mucoidacinetobacterbaumanniienhancesantiphagocytosisthroughreducingc3bdeposition
AT wuyifan mucoidacinetobacterbaumanniienhancesantiphagocytosisthroughreducingc3bdeposition
AT zhouhongwei mucoidacinetobacterbaumanniienhancesantiphagocytosisthroughreducingc3bdeposition
AT dingshuangyang mucoidacinetobacterbaumanniienhancesantiphagocytosisthroughreducingc3bdeposition
AT zhukui mucoidacinetobacterbaumanniienhancesantiphagocytosisthroughreducingc3bdeposition